Medical Communications

To print or download a PDF version of this article, click here.

It’s been a week for successful trial news and for drugs being sped through the approval process. Particularly noteworthy is …

Continuous manufacturing has long been touted as the future of drug production. Pharmafile approached Novartis for more details about its successes in …

Eli Lilly has announced a strategic collaboration with KeyBioscience that sees the former company gain access to develop and commercialise …

Idorsia, the spin-off R&D company of Actelion, has been hit a blow even before it has left the ground. The …

The FDA, since the appointment of Scott Gottlieb as commissioner, has made strong noises about tackling the opioid crisis and …

If you want to understand the importance of data, look at Google and Facebook – neither company is out of …

The human papillomavirus (HPV) vaccine began to be implemented in the UK in 2008. It started by immunising girls between …

To view the original whitepaper from NDA, please click here.Small and Medium Sized Companies in North America Lead Novel Drug …

Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) …

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …

Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common type of dementia (60–70%)[1], causing problems with memory, language, …

Abbvie has announced a double appointment across its UK and French operations, naming Jérôme Bouyer as its UK General Manager, …

The ABPI has moved to appoint Saratha Rajeswaran to the position of Executive Director of Government Affairs and Devolved Nations. …

New Phase 3 trial data has found that AstraZeneca’s Lynparza (olaparib) provides sustained quality of life (QoL) and improved progression-free …